Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 8, 2024
Osteosarcoma,
a
highly
aggressive
malignant
bone
tumor,
is
significantly
influenced
by
the
intricate
interactions
within
its
tumor
microenvironment
(TME),
particularly
involving
neutrophils.
This
review
delineates
multifaceted
roles
of
neutrophils,
including
tumor-associated
neutrophils
(TANs)
and
neutrophil
extracellular
traps
(NETs),
in
osteosarcoma’s
pathogenesis.
TANs
exhibit
both
pro-
anti-tumor
phenotypes,
modulating
growth
immune
evasion,
while
NETs
facilitate
cell
adhesion,
migration,
immunosuppression.
Clinically,
neutrophil-related
markers
such
as
neutrophil-to-lymphocyte
ratio
(NLR)
predict
patient
outcomes,
highlighting
potential
for
neutrophil-targeted
therapies.
Unraveling
these
complex
crucial
developing
novel
treatment
strategies
that
harness
TME
to
improve
osteosarcoma
management.
Biological Procedures Online,
Journal Year:
2025,
Volume and Issue:
27(1)
Published: March 10, 2025
Tumor-associated
macrophages
(TAMs)
are
crucial
in
hepatocellular
carcinoma
(HCC)
development
and
invasion.
This
study
explores
monocyte/
macrophage-associated
gene
expression
profiles
HCC,
constructs
a
prognostic
model
based
on
these
genes,
examines
its
relationship
with
drug
resistance
immune
therapy
responses.
Single-cell
RNA
sequencing(scRNA-seq)
data
from
10
HCC
tissue
biopsy
samples,
totaling
24,597
cells,
were
obtained
the
GEO
database
to
identify
monocyte/macrophage-associated
genes.
A
was
constructed
validated
using
external
datasets
Western
blot.
Relationships
between
model,
clinical
correlates,
sensitivity,
responses
investigated.
From
scRNA-seq
data,
2,799
monocyte/macrophage
marker
genes
identified.
Using
TCGA
dataset,
single-gene
UQCRH
constructed,
stratifying
patients
into
high-risk
low-risk
groups
overall
survival
rates.
High-risk
group
showed
reduced
rates
higher
tumor
tissues.
blot
analysis
further
confirmed
elevated
of
cell
lines.
Spatial
transcriptomics
revealed
that
high
co-localized
malignant
cells
tissue.
Drug
sensitivity
had
lower
sorafenib
axitinib.
Immune
response
indicated
poorer
outcomes
group,
more
pronounced
APC
inhibition
weaker
IFN-II
response.
Clinical
indicator
positive
correlation
Enrichment
associated
molecules
involvement
oxidative
phosphorylation
mitochondrial
electron
transport.
introduces
for
The
predicts
patient
treatment
outcomes,
identifying
individuals
varying
sensitivities
suppression
states.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 7, 2025
Abstract
The
impact
on
prognosis
of
neutrophil
infiltration
in
the
microenvironment
ovarian
cancer
remains
to
be
elucidated.
In
this
study,
we
analyzed
association
between
peritoneal
metastasis
and
prognosis.
Furthermore,
correlation
number
peripheral
blood
neutrophils,
degree
neutropenia,
vascular
endothelial
area,
stromal
cells.
Thirty-four
specimens
each
primary
metastatic
advanced
with
high-grade
serous
carcinoma
histology
were
taken.
Staining
for
MPO,
CD31,
αSMA
was
performed
all
specimens.
We
investigated
among
tissue
infiltration,
prognosis,
indicators
from
tests.
Survival
analysis
showed
that
tumor
had
no
whereas
high
disseminated
significantly
shortened
progression-free
survival
overall
survival.
No
found
area
cells,
Neutrophil
into
lesions
omentum
has
a
significant
results
present
study
may
provide
insights
refining
clinical
approaches.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(8), P. e19147 - e19147
Published: Aug. 1, 2023
Recent
immunotherapy
research
has
focused
on
chimeric
antigen
receptor-modified
T
cells
(CAR-Ts).
CAR-T
therapies
have
been
clinically
applied
to
manage
hematologic
malignancies
with
satisfactory
effectiveness.
However,
the
application
of
in
solid
tumors
remains
challenging.
Even
so,
current
immunotherapies
for
prostate
cancer
(PCa)
shown
some
promise,
giving
hope
patients
advanced
metastatic
PCa.
This
review
aimed
elucidate
different
types
tumor-associated
targets,
such
as
prostate-specific
membrane
and
stem
cell
antigen,
their
effects.
The
status
corresponding
targets
clinical
through
applications
was
also
discussed.
To
improve
efficacy
immunotherapy,
we
addressed
possible
multimodal
chemotherapy,
combined
therapies.
obstacles
were
concisely
elaborated.
Further
studies
should
aim
discover
novel
potential
establish
new
models
by
overcoming
inherent
barriers
tumors,
tumor
heterogeneity
immunosuppressive
nature
microenvironment.
Science Translational Medicine,
Journal Year:
2024,
Volume and Issue:
16(771)
Published: Oct. 30, 2024
Glioblastoma
presents
a
formidable
clinical
challenge
because
of
its
complex
microenvironment.
Here,
we
characterized
tumor-associated
foam
cells
(TAFs),
type
lipid
droplet–loaded
macrophage,
in
human
glioblastoma.
Through
extensive
analyses
patient
tumors,
together
with
vitro
and
vivo
investigations,
found
that
TAFs
exhibit
distinct
protumorigenic
characteristics
related
to
hypoxia,
mesenchymal
transition,
angiogenesis,
impaired
phagocytosis,
their
presence
correlates
worse
outcomes
for
patients
glioma.
We
further
demonstrated
TAF
formation
is
facilitated
by
scavenging
from
extracellular
vesicles
released
glioblastoma
cells.
targeting
key
enzymes
involved
droplet
formation,
such
as
diacylglycerol
O
-acyltransferase
or
long-chain
acyl-CoA
synthetase,
effectively
disrupted
functionality.
Together,
these
data
highlight
prominent
immune
cell
population
provide
insights
into
contribution
the
tumor
Disrupting
target
may
represent
an
avenue
future
therapeutic
development
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Oct. 31, 2024
Prostate
cancer
ranks
as
the
second
most
frequently
diagnosed
in
men
worldwide.
Recent
research
highlights
crucial
roles
IL6ST-mediated
signaling
pathways
play
development
and
progression
of
various
cancers,
particularly
through
hyperactivated
STAT3
signaling.
However,
molecular
programs
mediated
by
IL6ST/STAT3
prostate
are
poorly
understood.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(24), P. 17273 - 17273
Published: Dec. 8, 2023
Neutrophils
are
considered
as
the
main
player
in
innate
immunity.
In
last
few
years,
it
has
been
shown
that
they
involved
different
physiological
conditions
and
diseases.
However,
progress
field
of
neutrophil
biology
is
relatively
slow
due
to
existing
difficulties
isolation
maintenance
culture.
Here
we
compare
four
protocols
based
on
density-gradient
immunomagnetic
methods
for
murine
neutrophils
from
bone
marrow
spleen.
Neutrophil
was
performed
using
Ficoll
1.077/1.119
g/mL
density
gradient,
1.083/1.090/1.110
gradient
method
negative
positive
selection.
The
were
compared
with
respect
sample
purity,
cell
viability,
yield,
cost.
functionality
isolated
checked
by
NETosis
analysis
oxidative
burst
test.
Obtained
data
revealed
given
purity/yield/viability/cost
ratio
protocol
centrifugation
recommended
marrow,
whereas
selection
Dynabeads
splenic
neutrophils.
OncoImmunology,
Journal Year:
2023,
Volume and Issue:
12(1)
Published: Aug. 1, 2023
Chemotherapy
is
the
standard
of
care
for
most
malignancies.
Its
tumor
debulking
effect
in
adjuvant
or
neoadjuvant
settings
unquestionable,
although
secondary
effects
have
been
reported
that
paradoxically
promote
metastasis.
affects
hematopoietic
precursors
leading
to
myelosuppression,
with
neutropenia
being
main
hematological
toxicity
induced
by
cytotoxic
therapy.
We
used
renal
and
lung
murine
models
metastatic
study
chemotherapy-induced
(CIN)
process.
Cyclophosphamide
doxorubicin,
two
myelosuppressive
drugs,
but
not
cisplatin,
increased
burden
artificial
metastases
lung,
reducing
neutrophils.
This
was
recapitulated
treatment
anti-Ly6G,
selective
antibody-mediated
neutrophil
depletion
unleashed
formation
both
spontaneous
metastasis
settings.
The
cancer
dissemination
reversed
granulocyte-colony
stimulating
factor-mediated
boosting
neutrophils
combination
chemotherapy.
CIN
affected
early
colonization
quite
likely
promoting
proliferation
cells
extravasated
into
at
24-72
hours.
did
affect
late
events
process,
established
nor
there
any
on
release
from
primary,
whose
growth
was,
fact,
somewhat
inhibited.
work
suggests
a
role
associated
common
side
claims
deep
dive
relationship
between
Cancers,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4132 - 4132
Published: Dec. 11, 2024
Breast
cancer
(BC),
a
major
cause
of
death
among
women
worldwide,
has
traditionally
been
linked
to
genetic
and
environmental
factors.
However,
emerging
research
highlights
the
gut
microbiome’s
significant
role
in
shaping
BC
development,
progression,
treatment
outcomes.
This
review
explores
intricate
relationship
between
microbiota
breast
tumor
microenvironment,
emphasizing
how
these
microbes
influence
immune
responses,
inflammation,
metabolic
pathways.
Certain
bacterial
species
either
contribute
or
hinder
progression
by
producing
metabolites
that
affect
hormone
metabolism,
system
pathways,
cellular
signaling.
An
imbalance
bacteria,
known
as
dysbiosis,
associated
with
heightened
risk
BC,
like
short-chain
fatty
acids
(SCFAs)
enzymes
such
β-glucuronidase
playing
key
roles
this
process.
Additionally,
can
impact
effectiveness
chemotherapy,
certain
bacteria
degrade
drugs
gemcitabine
irinotecan,
leading
reduced
efficacy.
Understanding
complex
interactions
may
pave
way
for
innovative
approaches,
including
personalized
microbiome-targeted
therapies,
probiotics
fecal
transplants,
offering
new
hope
more
effective
prevention,
diagnosis,
BC.